Not applicableStudy completedNCT03225365What this trial is testingNivolumab +/- Ipilimumab Immunomonitoring in Metastatic MelanomaWho this might be right forMetastatic Melanoma Hospices Civils de Lyon 5
Testing effectiveness (Phase 2)UnknownNCT05142865What this trial is testingCamrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine CarcinomasWho this might be right forAdvanced or Metastatic EP-NEC Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Ended earlyNCT00496223What this trial is testingA Phase I/II Study of Sunitinib and DacarbazineWho this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Not applicableLooking for participantsNCT07422779What this trial is testingImmunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in SloveniaWho this might be right forMetastatic MelanomaSkin Cancer Institute of Oncology Ljubljana 100
Testing effectiveness (Phase 2)Ended earlyNCT02974803What this trial is testingConcurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain MetastasesWho this might be right forMelanomaBrain Metastases Canadian Cancer Trials Group 6
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Early research (Phase 1)Study completedNCT00453050What this trial is testingImiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the SkinWho this might be right forMelanoma (Skin)Metastatic Cancer University of Oklahoma 11
Not applicableAvailableNCT04960891What this trial is testingA Cohort IND Expanded Access Program for Supporting Patient Access to TebentafuspWho this might be right forUveal Melanoma Immunocore Ltd
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT02259725What this trial is testingRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more University of Southern California 3
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT01064713What this trial is testingPhase II Study of Tesetaxel in Metastatic MelanomaWho this might be right forAdvanced MelanomaCancer M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)UnknownNCT04021420What this trial is testingSafety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With MelanomaWho this might be right forMelanomaMetastatic Melanoma Assistance Publique - Hôpitaux de Paris 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Testing effectiveness (Phase 2)Looking for participantsNCT04325425What this trial is testingChemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown PrimaryWho this might be right forNeuroendocrine Carcinoma Centre Hospitalier Universitaire Dijon 218
Very early researchStudy completedNCT02652455What this trial is testingCombining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic MelanomaWho this might be right forMelanoma (Skin)Skin Cancer H. Lee Moffitt Cancer Center and Research Institute 11
Not applicableWithdrawnNCT02507076What this trial is testingIsolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWho this might be right forBasal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT02304458What this trial is testingNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasWho this might be right forMetastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Ended earlyNCT01009515What this trial is testingCarboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic MelanomaWho this might be right forMelanoma New Mexico Cancer Research Alliance 19